VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adjustment Disorder

NEXT STORY
Global Infectious Disease Diagnostic Market to Reach $39.9 Billion by 2030: Allied Market Research
PREV STORY
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body’s T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore’s Duke-NUS Medical
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rhythm Pharmaceuticals Announces New Clinical Data on Setmelanotide at ObesityWeek® 2020

author_avatar
NASDAQ Market News

Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC Published in European Radiology

PHP Therapy in ICC Treatment Shows Promise in Retrospective AnalysisNEW YORK, Oct. 04, 2018 ...

author_avatar
NASDAQ Market News

Timothy Keeler, BS-PA is Selected to the American Health Council’s Board of Physicians

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Timothy ...

author_avatar
NASDAQ Market News